PCN114 ASSESSMENT OF THE SURVIVAL BENEFIT AND COST IMPACT OF NEW TREATMENTS FOR KEY ANSCLC BIOMARKERS USING THE ITEN MODEL
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.311
https://www.valueinhealthjournal.com/article/S1098-3015(19)32689-0/fulltext
Title :
PCN114 ASSESSMENT OF THE SURVIVAL BENEFIT AND COST IMPACT OF NEW TREATMENTS FOR KEY ANSCLC BIOMARKERS USING THE ITEN MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32689-0&doi=10.1016/j.jval.2019.09.311
First page :
Section Title :
Open access? :
No
Section Order :
10255